SAS Output

13-JUL-2020 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1609-Rare Tumor, Comb Nivo/Ipi 1 Y 1 Nivolumab + Ipilimumab 818 730 149 32 14 2 0 01/30/2017 342 159
        2 Nivolumab single agent therapy   9 7 1 0 0 0      
            739 156 33 14 2 0      
 
Yes EAY131-MATCH 0 E Total Registrations   989 25 9 5 1 0 08/21/2015 379 207
            989 25 9 5 1 0      
 
    1 E Total Registrations   174 17 5 2 1 0 08/21/2015    
            174 17 5 2 1 0      
 
    2 E Total Registrations   8 0 0 0 0 0 08/21/2015    
            8 0 0 0 0 0      
 
    8 E Total Registrations   6 2 0 0 0 0 08/21/2015    
            6 2 0 0 0 0